FR2745974B1 - MODIFIED ANIMAL, USES AND METHOD FOR MEASURING THE EFFECTIVENESS OF A THERAPEUTIC PROCESS - Google Patents

MODIFIED ANIMAL, USES AND METHOD FOR MEASURING THE EFFECTIVENESS OF A THERAPEUTIC PROCESS

Info

Publication number
FR2745974B1
FR2745974B1 FR9603417A FR9603417A FR2745974B1 FR 2745974 B1 FR2745974 B1 FR 2745974B1 FR 9603417 A FR9603417 A FR 9603417A FR 9603417 A FR9603417 A FR 9603417A FR 2745974 B1 FR2745974 B1 FR 2745974B1
Authority
FR
France
Prior art keywords
effectiveness
measuring
therapeutic process
modified animal
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9603417A
Other languages
French (fr)
Other versions
FR2745974A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR9603417A priority Critical patent/FR2745974B1/en
Priority to EP97914408A priority patent/EP0825811A1/en
Priority to CA 2221028 priority patent/CA2221028A1/en
Priority to AU21658/97A priority patent/AU2165897A/en
Priority to JP9532343A priority patent/JPH11512623A/en
Priority to PCT/FR1997/000469 priority patent/WO1997033466A1/en
Publication of FR2745974A1 publication Critical patent/FR2745974A1/en
Application granted granted Critical
Publication of FR2745974B1 publication Critical patent/FR2745974B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Husbandry (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR9603417A 1996-03-14 1996-03-14 MODIFIED ANIMAL, USES AND METHOD FOR MEASURING THE EFFECTIVENESS OF A THERAPEUTIC PROCESS Expired - Fee Related FR2745974B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9603417A FR2745974B1 (en) 1996-03-14 1996-03-14 MODIFIED ANIMAL, USES AND METHOD FOR MEASURING THE EFFECTIVENESS OF A THERAPEUTIC PROCESS
EP97914408A EP0825811A1 (en) 1996-03-14 1997-03-14 Non-genetically modified mammal as a model for multiple sclerosis
CA 2221028 CA2221028A1 (en) 1996-03-14 1997-03-14 Non-genetically modified mammal as a model for multiple sclerosis
AU21658/97A AU2165897A (en) 1996-03-14 1997-03-14 Non-genetically modified mammal as a model for multiple sclerosis
JP9532343A JPH11512623A (en) 1996-03-14 1997-03-14 Non-genetically modified mammals as a model for multiple sclerosis
PCT/FR1997/000469 WO1997033466A1 (en) 1996-03-14 1997-03-14 Non-genetically modified mammal as a model for multiple sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9603417A FR2745974B1 (en) 1996-03-14 1996-03-14 MODIFIED ANIMAL, USES AND METHOD FOR MEASURING THE EFFECTIVENESS OF A THERAPEUTIC PROCESS

Publications (2)

Publication Number Publication Date
FR2745974A1 FR2745974A1 (en) 1997-09-19
FR2745974B1 true FR2745974B1 (en) 1998-04-17

Family

ID=9490322

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9603417A Expired - Fee Related FR2745974B1 (en) 1996-03-14 1996-03-14 MODIFIED ANIMAL, USES AND METHOD FOR MEASURING THE EFFECTIVENESS OF A THERAPEUTIC PROCESS

Country Status (6)

Country Link
EP (1) EP0825811A1 (en)
JP (1) JPH11512623A (en)
AU (1) AU2165897A (en)
CA (1) CA2221028A1 (en)
FR (1) FR2745974B1 (en)
WO (1) WO1997033466A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2797402B1 (en) 1999-07-15 2004-03-12 Biomerieux Stelhys USE OF A POLYPEPTIDE FOR DETECTING, PREVENTING OR TREATING A CONDITION ASSOCIATED WITH A DEGENERATIVE, NEUROLOGICAL OR AUTOIMMUNE DISEASE
WO2005067708A2 (en) * 2004-01-14 2005-07-28 Daniolabs Limited Zebrafish model for autoimmune diseases
WO2016022387A2 (en) * 2014-08-07 2016-02-11 Tisch Multiple Sclerosis Research Center Of New York A mouse model for multiple sclerosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716198B1 (en) * 1994-02-15 1996-04-19 Bio Merieux Cytotoxic factor as associated with multiple sclerosis, its detection and quantification.
EP0685558A1 (en) * 1994-05-27 1995-12-06 Bayer Ag Transgenic animals lacking proteolipid protein and method of making such animals

Also Published As

Publication number Publication date
WO1997033466A1 (en) 1997-09-18
AU2165897A (en) 1997-10-01
FR2745974A1 (en) 1997-09-19
CA2221028A1 (en) 1997-09-18
JPH11512623A (en) 1999-11-02
EP0825811A1 (en) 1998-03-04

Similar Documents

Publication Publication Date Title
FR2726410B1 (en) METHOD AND APPARATUS FOR INCREASING THE EFFICIENCY OF AN AMPLIFIER
FR2703365B1 (en) Apparatus and method for electroplating.
FR2736817B1 (en) METHOD AND DEVICE FOR REINFORCING SURGICAL STAPLERS
FR2773410B1 (en) TEACHING SYSTEM AND METHOD
FR2742126B1 (en) DEPALETTIZATION PROCESS AND RESULTING PALETTE
FI963476A (en) Method and apparatus for preventing agglomeration
FR2714108B1 (en) Directional drilling method and apparatus.
FR2687687B1 (en) METHOD FOR MEASURING THE SIZE OF DNA FRAGMENTS.
FR2734923B1 (en) ELASTIC BLADE, DEVELOPMENT DEVICE USING THE SAME, AND METHOD FOR THE PRODUCTION THEREOF
FR2765137B1 (en) METHOD AND DEVICE FOR MANUFACTURING NARROW VENEER STRIPS
FR2725704B1 (en) MACHINE AND METHOD FOR SHREDDING BULK-FEED OBJECTS
IT1277904B1 (en) METHOD FOR DETERMINING THE THERAPEUTIC ACTIVITY OF METALLOPROTEINASE INHIBITOR COMPOUNDS, NEW INHIBITOR COMPOUNDS, AND THEIR USE
DE69514960T2 (en) Slag treatment system and method
FR2747212B1 (en) PRINTER AND FORCED PRINTER STOPPING METHOD
BR9608672A (en) Ferritic steel and process for its manufacture and use
FR2745974B1 (en) MODIFIED ANIMAL, USES AND METHOD FOR MEASURING THE EFFECTIVENESS OF A THERAPEUTIC PROCESS
FR2727622B3 (en) LIFTING APPARATUS AND METHOD FOR POSITIONING A PERSON
FR2765485B1 (en) METHOD AND APPARATUS FOR ANTI-ODOR AIR TREATMENT
FR2719367B1 (en) Refrigerant process and device.
FR2716819B1 (en) Casting method and device.
FR2702340B1 (en) DEBUDGING PROCESS AND MACHINE, ESPECIALLY FOR CASSISSIERS.
TR27462A (en) Substituted cinnamic acid hydroxyamides, the method for their production, the substances containing them and their use.
FR2707877B1 (en) Method for preserving donkey milk and its therapeutic and cosmetological applications.
FR2731365B1 (en) GLYCOLIPIDIC SURFACTANT AND PROCESS FOR ITS PREPARATION
FR2768654B1 (en) PROCESS AND DEVICE FOR THE PREPARATION OF A DOCUMENT WITH VARIABLE INSCRIPTIONS

Legal Events

Date Code Title Description
ST Notification of lapse